NCT05394675 A Study of DS-9606a in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT05394103 Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05375994 Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05364905 Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma Status COMPLETED Phase N/A
NCT05315999 Protreat-Trial: Prophylactic Antiemetic Treatment of Opioid-induced Nausea and Vomiting (OINV) in Palliative Care Status COMPLETED Phase PHASE2
NCT05315427 Impact of Music Therapy on Pain in Patients Treated for Advanced Cancer Status COMPLETED Phase NA
NCT05298592 A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors Status COMPLETED Phase PHASE1
NCT05276310 A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy Status RECRUITING Phase PHASE1
NCT05270213 Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT05257590 CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma Status RECRUITING Phase PHASE2
NCT05204147 Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers Status SUSPENDED Phase PHASE1
NCT05192512 Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers Status UNKNOWN Phase PHASE1
NCT05166694 Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions Status RECRUITING Phase NA
NCT05162443 Expanded Access of Adagrasib (MRTX849) in Patients With Advanced Solid Tumors Who Have a KRAS G12C Mutation Status APPROVED_FOR_MARKETING Phase N/A
NCT05159245 The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs Status RECRUITING Phase PHASE2
NCT05154630 Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT05142345 Care Transition Intervention for Hospitalized Patients With Advanced Cancer Status COMPLETED Phase NA